Rheumatoid arthritis is the most common chronic inflammatory joint disease, affecting approximately 2.8 million adults in the United States. Symptoms include fatigue, swelling, pain and stiffness of the joints, and these manifestations may vary in a predictable pattern throughout the day. This Special Report discusses the present state of RA along with clinical studies of a novel, delayed-release formulation of prednisone to reduce the early morning peak in cytokine activity and to diminish the severity of morning RA symptoms.

Download to read this article in PDF document:

Delayed-Release Prednisone in Rheumatoid Arthritis: Treatment Considerations

Full Prescribing Information for RAYOS

This article is in PDF format and it requires Abobe Reader. If you do not have Adobe Reader installed on your computer then please download and install from the link below.